Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Body Composition | 29 | 2024 | 562 | 2.560 |
Why?
|
| Absorptiometry, Photon | 24 | 2022 | 206 | 1.700 |
Why?
|
| Adipose Tissue | 14 | 2020 | 510 | 1.280 |
Why?
|
| Whole-Body Counting | 4 | 2017 | 6 | 1.110 |
Why?
|
| Phantoms, Imaging | 6 | 2013 | 142 | 1.090 |
Why?
|
| Bone Density | 22 | 2022 | 375 | 1.070 |
Why?
|
| Bone and Bones | 10 | 2022 | 311 | 0.650 |
Why?
|
| Thallium | 1 | 2017 | 8 | 0.550 |
Why?
|
| Iodides | 1 | 2017 | 15 | 0.540 |
Why?
|
| Radiation Monitoring | 1 | 2017 | 16 | 0.540 |
Why?
|
| Sodium | 4 | 2017 | 309 | 0.520 |
Why?
|
| Monte Carlo Method | 2 | 2017 | 102 | 0.480 |
Why?
|
| Renal Dialysis | 2 | 2018 | 891 | 0.440 |
Why?
|
| Whole Body Imaging | 1 | 2013 | 31 | 0.420 |
Why?
|
| Models, Anatomic | 1 | 2013 | 104 | 0.390 |
Why?
|
| Pediatric Obesity | 4 | 2022 | 410 | 0.370 |
Why?
|
| Energy Metabolism | 4 | 2024 | 814 | 0.370 |
Why?
|
| Body Mass Index | 7 | 2024 | 1719 | 0.350 |
Why?
|
| Body Weight | 11 | 2017 | 1041 | 0.340 |
Why?
|
| Calibration | 4 | 2022 | 100 | 0.310 |
Why?
|
| Models, Biological | 6 | 2024 | 1539 | 0.290 |
Why?
|
| Child | 30 | 2024 | 25890 | 0.290 |
Why?
|
| Basal Metabolism | 3 | 2024 | 95 | 0.290 |
Why?
|
| Weight Gain | 4 | 2019 | 413 | 0.280 |
Why?
|
| beta-Glucans | 3 | 2013 | 20 | 0.270 |
Why?
|
| Pregnancy, Twin | 2 | 2018 | 189 | 0.270 |
Why?
|
| Breast Feeding | 2 | 2020 | 245 | 0.260 |
Why?
|
| Isoflavones | 3 | 2013 | 46 | 0.260 |
Why?
|
| Obesity | 8 | 2019 | 2446 | 0.260 |
Why?
|
| Insulin Resistance | 3 | 2022 | 700 | 0.260 |
Why?
|
| Infant, Premature | 5 | 2020 | 858 | 0.260 |
Why?
|
| Adolescent | 23 | 2024 | 20624 | 0.250 |
Why?
|
| Milk, Human | 2 | 2020 | 311 | 0.240 |
Why?
|
| Fetal Development | 2 | 2018 | 135 | 0.240 |
Why?
|
| Child, Preschool | 18 | 2024 | 14884 | 0.230 |
Why?
|
| Calorimetry | 1 | 2024 | 63 | 0.230 |
Why?
|
| Anthropometry | 5 | 2018 | 205 | 0.230 |
Why?
|
| Software | 3 | 2008 | 735 | 0.220 |
Why?
|
| Humans | 54 | 2024 | 134156 | 0.210 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 238 | 0.200 |
Why?
|
| Adiposity | 3 | 2022 | 207 | 0.200 |
Why?
|
| Cardiorespiratory Fitness | 1 | 2022 | 10 | 0.200 |
Why?
|
| Potassium | 7 | 2015 | 290 | 0.200 |
Why?
|
| Female | 37 | 2024 | 71928 | 0.190 |
Why?
|
| Pregnancy Trimesters | 2 | 2018 | 34 | 0.190 |
Why?
|
| Osteoporosis | 2 | 2019 | 141 | 0.180 |
Why?
|
| Body Height | 4 | 2018 | 230 | 0.180 |
Why?
|
| Male | 32 | 2024 | 66127 | 0.180 |
Why?
|
| Dietary Supplements | 4 | 2018 | 489 | 0.170 |
Why?
|
| Osteosclerosis | 1 | 2020 | 12 | 0.170 |
Why?
|
| Reference Values | 7 | 2018 | 741 | 0.160 |
Why?
|
| Reproducibility of Results | 9 | 2008 | 3043 | 0.160 |
Why?
|
| Exercise | 3 | 2021 | 869 | 0.160 |
Why?
|
| Birth Weight | 2 | 2018 | 354 | 0.160 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2022 | 167 | 0.160 |
Why?
|
| Dwarfism | 1 | 2020 | 105 | 0.160 |
Why?
|
| Limb Deformities, Congenital | 1 | 2020 | 112 | 0.160 |
Why?
|
| Postmenopause | 2 | 2010 | 155 | 0.160 |
Why?
|
| Calcium | 7 | 2009 | 1148 | 0.150 |
Why?
|
| Twins, Dizygotic | 1 | 2018 | 48 | 0.150 |
Why?
|
| Docosahexaenoic Acids | 1 | 2019 | 68 | 0.150 |
Why?
|
| Infant | 11 | 2020 | 13240 | 0.150 |
Why?
|
| Minerals | 1 | 1998 | 59 | 0.150 |
Why?
|
| Skeleton | 1 | 1998 | 4 | 0.150 |
Why?
|
| Spectrum Analysis | 1 | 2018 | 69 | 0.150 |
Why?
|
| Age Factors | 7 | 2011 | 2998 | 0.150 |
Why?
|
| Craniofacial Abnormalities | 1 | 2020 | 253 | 0.150 |
Why?
|
| Urogenital Abnormalities | 1 | 2020 | 164 | 0.150 |
Why?
|
| Body Water | 5 | 2018 | 90 | 0.150 |
Why?
|
| Young Adult | 5 | 2024 | 9944 | 0.140 |
Why?
|
| Overweight | 2 | 2024 | 387 | 0.140 |
Why?
|
| Scintillation Counting | 1 | 2017 | 6 | 0.140 |
Why?
|
| Infant Nutritional Physiological Phenomena | 2 | 2017 | 198 | 0.140 |
Why?
|
| Child Development | 1 | 2020 | 286 | 0.140 |
Why?
|
| Rothmund-Thomson Syndrome | 1 | 2017 | 47 | 0.130 |
Why?
|
| Equipment Failure Analysis | 1 | 2017 | 87 | 0.130 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 3754 | 0.130 |
Why?
|
| Adult | 19 | 2022 | 31945 | 0.130 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 868 | 0.130 |
Why?
|
| Infant Formula | 1 | 2017 | 100 | 0.130 |
Why?
|
| Nutritional Status | 1 | 2018 | 325 | 0.130 |
Why?
|
| Infant, Newborn | 10 | 2020 | 8623 | 0.130 |
Why?
|
| Proteins | 2 | 2018 | 1101 | 0.120 |
Why?
|
| Energy Intake | 1 | 2018 | 518 | 0.120 |
Why?
|
| Fractures, Bone | 1 | 2017 | 211 | 0.120 |
Why?
|
| Equipment Design | 1 | 2017 | 608 | 0.120 |
Why?
|
| Diet | 3 | 2020 | 1195 | 0.120 |
Why?
|
| Regression Analysis | 4 | 2008 | 827 | 0.110 |
Why?
|
| Swine | 6 | 2019 | 1219 | 0.110 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2015 | 51 | 0.110 |
Why?
|
| Polyvinyl Chloride | 1 | 2013 | 2 | 0.110 |
Why?
|
| Computer Simulation | 1 | 2017 | 707 | 0.110 |
Why?
|
| Polyethylene | 1 | 2013 | 15 | 0.110 |
Why?
|
| Hypertension | 1 | 2022 | 1398 | 0.110 |
Why?
|
| Nylons | 1 | 2013 | 13 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 289 | 0.100 |
Why?
|
| Camping | 1 | 2013 | 14 | 0.100 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 691 | 0.100 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 141 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1506 | 0.100 |
Why?
|
| Quality of Life | 2 | 2013 | 2160 | 0.100 |
Why?
|
| Menopause | 1 | 2013 | 91 | 0.100 |
Why?
|
| Weight Loss | 2 | 2015 | 516 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 213 | 0.100 |
Why?
|
| Weight Reduction Programs | 1 | 2013 | 60 | 0.090 |
Why?
|
| Self Concept | 1 | 2013 | 163 | 0.090 |
Why?
|
| Growth and Development | 1 | 2011 | 23 | 0.090 |
Why?
|
| Metabolic Syndrome | 1 | 2015 | 365 | 0.090 |
Why?
|
| Phytoestrogens | 1 | 2010 | 16 | 0.090 |
Why?
|
| Blood Urea Nitrogen | 1 | 2010 | 77 | 0.090 |
Why?
|
| Neutron Activation Analysis | 4 | 1999 | 7 | 0.090 |
Why?
|
| Marfan Syndrome | 1 | 2012 | 150 | 0.080 |
Why?
|
| Cohort Studies | 5 | 2024 | 5222 | 0.080 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 2009 | 12 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2010 | 138 | 0.080 |
Why?
|
| Injections, Intramuscular | 1 | 2009 | 198 | 0.080 |
Why?
|
| Growth Hormone | 1 | 2009 | 151 | 0.080 |
Why?
|
| Plasmids | 1 | 2009 | 529 | 0.070 |
Why?
|
| Body Fluid Compartments | 2 | 2018 | 19 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 2172 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 915 | 0.070 |
Why?
|
| Plethysmography | 1 | 2007 | 35 | 0.070 |
Why?
|
| Risk Factors | 4 | 2022 | 11182 | 0.070 |
Why?
|
| Placebos | 4 | 2013 | 240 | 0.070 |
Why?
|
| Potassium Radioisotopes | 3 | 2015 | 7 | 0.060 |
Why?
|
| Sex Factors | 2 | 2008 | 1387 | 0.060 |
Why?
|
| Vitamin D | 3 | 2018 | 180 | 0.060 |
Why?
|
| Body Constitution | 2 | 1998 | 42 | 0.060 |
Why?
|
| Gestational Age | 3 | 2018 | 1229 | 0.060 |
Why?
|
| Software Validation | 1 | 2004 | 11 | 0.060 |
Why?
|
| Lumbar Vertebrae | 2 | 2022 | 114 | 0.060 |
Why?
|
| Pregnancy | 4 | 2019 | 7570 | 0.060 |
Why?
|
| Receptors, Calcitriol | 1 | 2005 | 74 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2019 | 6601 | 0.060 |
Why?
|
| Femur | 2 | 2020 | 75 | 0.060 |
Why?
|
| Middle Aged | 8 | 2020 | 29399 | 0.050 |
Why?
|
| Indicator Dilution Techniques | 1 | 2022 | 25 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 2 | 1993 | 261 | 0.050 |
Why?
|
| Deuterium | 1 | 2022 | 109 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 2090 | 0.050 |
Why?
|
| Blood Pressure Determination | 1 | 2022 | 115 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 897 | 0.040 |
Why?
|
| Wnt-5a Protein | 1 | 2020 | 24 | 0.040 |
Why?
|
| Soybean Proteins | 1 | 2000 | 17 | 0.040 |
Why?
|
| Dishevelled Proteins | 1 | 2020 | 45 | 0.040 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2020 | 36 | 0.040 |
Why?
|
| Glypicans | 1 | 2020 | 41 | 0.040 |
Why?
|
| Arthritis, Juvenile | 1 | 2000 | 42 | 0.040 |
Why?
|
| Linear Models | 1 | 2001 | 723 | 0.040 |
Why?
|
| Olive Oil | 1 | 2019 | 24 | 0.040 |
Why?
|
| Emulsions | 1 | 2019 | 70 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 488 | 0.040 |
Why?
|
| Soybean Oil | 1 | 2019 | 71 | 0.040 |
Why?
|
| Aftercare | 1 | 2020 | 156 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2001 | 419 | 0.040 |
Why?
|
| Fish Oils | 1 | 2019 | 84 | 0.040 |
Why?
|
| Dietary Proteins | 1 | 2000 | 252 | 0.040 |
Why?
|
| Living Donors | 1 | 2019 | 118 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2013 | 1665 | 0.040 |
Why?
|
| Thinness | 1 | 1998 | 77 | 0.030 |
Why?
|
| Nutritional Requirements | 1 | 2018 | 180 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2000 | 342 | 0.030 |
Why?
|
| Medroxyprogesterone | 1 | 1997 | 8 | 0.030 |
Why?
|
| Animals | 8 | 2019 | 36557 | 0.030 |
Why?
|
| Amenorrhea | 1 | 1997 | 21 | 0.030 |
Why?
|
| Bone Remodeling | 1 | 2017 | 59 | 0.030 |
Why?
|
| Contraceptives, Oral | 1 | 1997 | 41 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2020 | 330 | 0.030 |
Why?
|
| RecQ Helicases | 1 | 2017 | 64 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2018 | 229 | 0.030 |
Why?
|
| Models, Structural | 2 | 1994 | 50 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2022 | 1421 | 0.030 |
Why?
|
| Hypothalamic Diseases | 1 | 1997 | 38 | 0.030 |
Why?
|
| Lactation | 1 | 2018 | 200 | 0.030 |
Why?
|
| Texas | 4 | 2015 | 3716 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2017 | 168 | 0.030 |
Why?
|
| Triglycerides | 1 | 2019 | 617 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2020 | 519 | 0.030 |
Why?
|
| Prevalence | 1 | 2022 | 2684 | 0.030 |
Why?
|
| Wasting Syndrome | 1 | 2015 | 27 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1493 | 0.030 |
Why?
|
| Mothers | 1 | 2018 | 370 | 0.030 |
Why?
|
| Peptide YY | 1 | 2015 | 19 | 0.030 |
Why?
|
| Analysis of Variance | 3 | 2005 | 1044 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2015 | 60 | 0.030 |
Why?
|
| Gastrointestinal Hormones | 1 | 2015 | 21 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 629 | 0.030 |
Why?
|
| Adipokines | 1 | 2015 | 73 | 0.030 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2020 | 545 | 0.030 |
Why?
|
| Leptin | 1 | 2015 | 224 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2020 | 1631 | 0.030 |
Why?
|
| Elements | 1 | 1993 | 1 | 0.030 |
Why?
|
| Time Factors | 4 | 2009 | 6610 | 0.030 |
Why?
|
| Gamma Rays | 1 | 1993 | 55 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 1218 | 0.020 |
Why?
|
| Fibrillins | 1 | 2012 | 31 | 0.020 |
Why?
|
| Fibrillin-1 | 1 | 2012 | 62 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2019 | 13074 | 0.020 |
Why?
|
| Pediatrics | 2 | 2018 | 1215 | 0.020 |
Why?
|
| Predictive Value of Tests | 3 | 2004 | 2301 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 2198 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1993 | 402 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 1993 | 176 | 0.020 |
Why?
|
| Hypocotyl | 1 | 2010 | 7 | 0.020 |
Why?
|
| Seasons | 1 | 2013 | 334 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2013 | 457 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2015 | 834 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 289 | 0.020 |
Why?
|
| United States | 2 | 2022 | 11763 | 0.020 |
Why?
|
| Endometrium | 1 | 2013 | 289 | 0.020 |
Why?
|
| Insulin | 1 | 2015 | 1260 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2009 | 56 | 0.020 |
Why?
|
| Europe | 2 | 2000 | 382 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2009 | 198 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 1040 | 0.020 |
Why?
|
| Mexican Americans | 2 | 2000 | 207 | 0.020 |
Why?
|
| Sex Characteristics | 2 | 2000 | 338 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2013 | 1004 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2009 | 352 | 0.020 |
Why?
|
| Eating | 1 | 2009 | 395 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 3224 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1740 | 0.020 |
Why?
|
| Inulin | 1 | 2005 | 19 | 0.010 |
Why?
|
| Fructans | 1 | 2005 | 12 | 0.010 |
Why?
|
| Biomarkers | 1 | 2015 | 3434 | 0.010 |
Why?
|
| Osteocalcin | 1 | 2005 | 50 | 0.010 |
Why?
|
| Immunoassay | 1 | 2005 | 139 | 0.010 |
Why?
|
| Femur Neck | 1 | 2004 | 15 | 0.010 |
Why?
|
| Chlorine | 2 | 1994 | 17 | 0.010 |
Why?
|
| Polysaccharides | 1 | 2005 | 152 | 0.010 |
Why?
|
| Hip Joint | 1 | 2004 | 46 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 6338 | 0.010 |
Why?
|
| Spine | 1 | 2004 | 147 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 3999 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 1357 | 0.010 |
Why?
|
| Models, Animal | 1 | 2004 | 486 | 0.010 |
Why?
|
| Dermatomyositis | 1 | 2001 | 35 | 0.010 |
Why?
|
| Animal Feed | 1 | 2000 | 83 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 19055 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1999 | 90 | 0.010 |
Why?
|
| Electric Impedance | 1 | 1999 | 68 | 0.010 |
Why?
|
| New York | 1 | 1999 | 73 | 0.010 |
Why?
|
| Growth | 1 | 1999 | 106 | 0.010 |
Why?
|
| Random Allocation | 1 | 1999 | 449 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 2001 | 266 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 2814 | 0.010 |
Why?
|
| Rett Syndrome | 1 | 2001 | 294 | 0.010 |
Why?
|
| Algorithms | 1 | 2004 | 1736 | 0.010 |
Why?
|
| Liver Diseases | 1 | 2001 | 392 | 0.010 |
Why?
|
| Phosphorus | 1 | 1994 | 61 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1997 | 481 | 0.010 |
Why?
|
| Cadaver | 1 | 1993 | 138 | 0.010 |
Why?
|
| HIV Infections | 1 | 2001 | 2075 | 0.000 |
Why?
|